Ergothioneine and Eye Health: Why Your Lens Contains It

Ergothioneine & Eye Health

Zero blood vessels in the lens

The human lens has no blood supply yet actively concentrates ergothioneine via OCTN1 transporters in its surface cells. When that accumulation fails, cataracts form.

Gründemann, FEBS Lett, 2022

OCTN1 confirmed

expressed in lens epithelial cells specifically

UV singlet oxygen

the primary lens threat ergothioneine is designed to neutralize

1981 human data

cataractous lenses show marked ergothioneine depletion vs normal lenses

Gründemann, FEBS Lett, 2022

View as image ↗

The human lens faces a problem that no other tissue in the body solves quite the same way. It has no blood supply. Its proteins are never replaced. And it sits in the direct path of every UV photon entering the eye. Ergothioneine lens accumulation isn't a coincidence — it's the lens's solution to this problem, actively orchestrated through a transporter protein that evolved specifically to concentrate this mushroom-derived antioxidant in tissue that has no other reliable way to get it.

The full story of ergothioneine as a longevity-relevant antioxidant runs broader than eye health. But the lens is one of the clearest examples of why the body's investment in an ergothioneine-specific transport system makes biological sense.

Why does ergothioneine accumulate in the lens? Lens epithelial cells express OCTN1 (SLC22A4), a dedicated transporter that actively pulls ergothioneine from the aqueous humor into the cell interior. UV light generates singlet oxygen in the lens continuously, and ergothioneine is one of the most effective singlet oxygen quenchers in human biology. The accumulation is targeted because the threat is specific.

The Lens Is the Eye's Most Oxidatively Stressed Tissue

Before asking how ergothioneine reaches the lens, it helps to understand why the lens needs it so badly.

The lens is a transparent, protein-dense structure whose job is to focus light onto the retina. Transparency depends on perfectly ordered crystallin proteins. Any structural change that scatters light produces opacity. And the lens's biology makes it uniquely vulnerable to the kind of structural changes that cause opacity.

First: lens proteins are never replaced. The crystallins synthesized in early development remain in the lens for a lifetime. Protein turnover, which most tissues use to replace oxidized proteins, is absent. Every oxidative hit to a lens protein is a permanent change.

Second: the lens has no blood supply. It receives nutrients from the aqueous humor by passive diffusion, with no blood vessel delivery system to bring a constant fresh supply of circulating antioxidants.

Third: the lens intercepts UV radiation. Much of the UV that enters the eye is absorbed by the lens before it can reach the retina. UV absorption generates singlet oxygen and hydrogen peroxide directly in lens tissue. Both damage the crystallin proteins whose structural integrity determines whether light passes through cleanly.

A tissue with permanent proteins, no blood supply, and continuous UV-driven oxidant generation needs a robust, active antioxidant system. The body's answer involves ergothioneine and a dedicated molecular import mechanism.

The Avascular Problem: How Anything Reaches the Lens

Because the lens has no blood vessels, any antioxidant that reaches it must travel a specific route: enter the bloodstream, cross into the aqueous humor, and then enter lens cells through transporters in the epithelial layer.

Most antioxidants that circulate in the blood don't concentrate efficiently in the lens because they rely on passive diffusion through the aqueous humor. Passive diffusion is slow and limited by concentration gradients. It can't maintain the high intracellular concentrations a tissue under continuous UV oxidative stress needs.

Active transport solves this. Transporter proteins in lens epithelial cells can pull molecules from the aqueous humor against a concentration gradient, using cellular energy to maintain concentrations far above what passive diffusion would achieve. The lens expresses these transporters selectively for the antioxidants it most depends on.

This is how ergothioneine reaches the lens — not by diffusing in, but by being actively imported by cells that specifically express the OCTN1 transporter.

OCTN1 Discovered: The Transporter the Body Built for Ergothioneine

In 2005, Gründemann and colleagues at the University of Cologne identified OCTN1 (SLC22A4) as the specific, dedicated transporter for ergothioneine.^[1] Before this work, ergothioneine's unusual pattern of tissue distribution — high concentrations in specific oxidative-stress-exposed tissues, low concentrations elsewhere — had been observed but not explained mechanistically.

The OCTN1 discovery provided the explanation. This transporter is expressed in tissues where ergothioneine accumulates. It actively concentrates ergothioneine intracellularly. It is not a broad antioxidant transporter handling many different molecules; it is specifically tuned to ergothioneine.

The discovery changed how researchers thought about ergothioneine. A compound that the body built dedicated transport infrastructure for isn't just a dietary antioxidant among many. The body is investing biological resources to ensure specific tissues have reliable access to it.

A Transporter That Evolved for One Molecule and One Molecule Only

If OCTN1 were a general-purpose transporter, its presence in the lens would be less informative. But it isn't.

In 2019, Tucker and colleagues tested OCTN1's substrate selectivity systematically, exposing the transporter to ergothioneine and a range of structurally similar compounds.^[2] OCTN1 showed extreme selectivity for ergothioneine, transporting it with far higher affinity and efficiency than any other compound tested. The transporter's binding site is precisely shaped for ergothioneine's molecular structure.

This specificity has an evolutionary implication. Proteins with such narrow substrate specificity generally evolved in response to specific biological pressures — the body needed to handle exactly this molecule, so a transporter evolved to handle exactly this molecule. If ergothioneine were biologically incidental, a general-purpose transporter would have been sufficient. The fact that an entire dedicated protein evolved to handle it suggests the body has been dealing with ergothioneine for a very long time and considers reliable access to it important.

For a deeper mechanistic treatment of OCTN1 biology in eye tissue, see OCTN1 in the Retina: Ergothioneine and Macular Degeneration.

Confirmed in Lens Tissue: Why Ergothioneine Lens Accumulation Is No Accident

Knowing OCTN1 exists and knowing it's selective for ergothioneine still leaves an anatomical question: is it actually expressed in the lens?

Gründemann's 2022 review provided a comprehensive inventory of all tissues expressing OCTN1 at significant levels.^[3] Lens epithelial cells are on that list. The same review confirmed OCTN1 expression in retinal pigment epithelium, the other key eye tissue under high oxidative stress.

This completes the mechanistic chain for lens ergothioneine accumulation. The lens epithelial cells that form the lens's outer layer express OCTN1. Those cells import ergothioneine from the aqueous humor into the cell interior. Ergothioneine then distributes into the deeper lens tissue where the crystallin proteins it needs to protect are located. The accumulation is not passive or incidental; it is actively maintained by the cells that constitute the lens's metabolically active outer layer.

The UV Connection: Ergothioneine Is Specifically Suited to the Lens's Main Threat

Knowing that the lens accumulates ergothioneine still leaves the question of mechanism: what does ergothioneine actually do when UV light hits the lens?

Two distinct pathways characterize its protective role. Cheah and Halliwell's authoritative 2021 review of ergothioneine research identifies singlet oxygen quenching as one of its primary protective functions in UV-exposed tissues.^[4] Singlet oxygen is the specific reactive species that UV generates in the lens. Ergothioneine neutralizes it chemically, before it can reach and oxidize crystallin proteins. Most common dietary antioxidants are not efficient singlet oxygen quenchers. Ergothioneine is an exception.

The second pathway involves gene expression. In 2024, Li and colleagues demonstrated that ergothioneine activates the PI3K/AKT/Nrf2 signaling cascade under UV-induced oxidative stress.^[5] Nrf2 is a transcription factor that, when activated, upregulates dozens of antioxidant and repair genes. The Nrf2 pathway is active in lens epithelial cells. Li 2024 used skin cells as the model, but the signaling mechanism translates to lens biology directly, because the UV challenge and the Nrf2 response are both present in lens epithelial cells.

Together, these two pathways explain why ergothioneine is particularly well-matched to the lens's specific oxidative challenge: it handles the acute chemistry (singlet oxygen neutralization) and also triggers the cellular response that keeps the lens's own antioxidant machinery switched on.

The Evolutionary Argument: Why the Body Maintained This Infrastructure

In 2018, biochemist Bruce Ames at UC Berkeley framed the bigger picture. He proposed that compounds for which the human body evolved dedicated transport infrastructure should be considered biologically essential — meaning deficiency leads to insidious long-term damage in exactly the high-stress tissues where the transporter is expressed.^[6]

Applied to the lens: OCTN1 is expressed in lens epithelial cells. The body maintains this transporter throughout life. The lens invests cellular energy to concentrate ergothioneine against its concentration gradient. These biological facts don't accumulate by accident. They represent an evolved system that the lens depends on for its long-term integrity.

Ames' argument provides the evolutionary framing for the anatomical observation. The lens can't replace its proteins, can't rely on blood supply, and faces continuous UV exposure for 70 or more years. Given those constraints, a dedicated import system for an efficient singlet oxygen quencher that also activates Nrf2 represents exactly the kind of solution that natural selection would maintain.

When It Depletes: The Cataract Connection as the Closing Evidence

The final piece of the story comes from 1981. Shukla and colleagues examined ergothioneine content in human lens tissue from cataract patients and from age-matched controls with healthy vision.^[7]

Cataractous lenses had markedly lower ergothioneine.

This is the punchline to the biological argument developed above. The lens has a dedicated system to import ergothioneine. Ergothioneine is specifically suited to neutralizing the UV-derived reactive oxygen species that damage lens proteins. Lens proteins are never replaced, so damage accumulates permanently. And the lenses that develop cataracts — the lenses where oxidative damage has accumulated to the point of causing opacity — have less ergothioneine than the lenses that don't.

The observation is associational and can't establish causation. No human clinical trial has tested ergothioneine supplementation for cataracts. But the biological system is coherent: the lens needs ergothioneine, builds dedicated machinery to acquire it, and loses clarity when that supply depletes.

For more detail on the cataract evidence specifically, including what the 1981 Shukla data can and cannot show, see Ergothioneine and Cataract Prevention.

What This Means for Dietary Intake

The lens depends on OCTN1 to maintain its ergothioneine supply. OCTN1 only imports ergothioneine that is available in the aqueous humor, which in turn reflects circulating plasma levels, which in turn reflect dietary intake and absorption.

Mushrooms are the primary dietary source of ergothioneine. Ergothioneine is synthesized by fungi and bacteria; for humans, fungi are the practical source. The compound is heat-stable and survives cooking. After absorption via OCTN1 transporters in intestinal cells, it enters the bloodstream and eventually reaches the aqueous humor, from which lens epithelial cells import it.

How much dietary ergothioneine actually reaches the lens, and at what plasma concentrations lens accumulation is optimized, isn't precisely characterized in humans. That is an open question for future research. What is established is the pathway: dietary intake raises plasma levels; plasma levels raise aqueous humor levels; OCTN1 imports from the aqueous humor into the lens.

For the species-by-species comparison of mushroom ergothioneine content, see Ergothioneine Content by Mushroom Species: A Complete Ranking. For the broader eye health evidence landscape, see Ergothioneine for Eye Health: Research and Implications.

The Bottom Line

The human lens accumulates ergothioneine via OCTN1 transporters in its epithelial cells because it faces continuous UV-driven oxidative stress with no blood supply and no capacity for protein replacement. OCTN1 shows extreme selectivity for ergothioneine, transporting it with far higher affinity than any other substrate — evidence the system evolved specifically for this molecule. Cataractous lenses contain markedly lower ergothioneine than normal lenses, connecting the transport system's integrity to clinical lens disease.

Frequently Asked Questions

Why does the eye accumulate ergothioneine?

The lens and retina face high continuous oxidative stress from UV radiation, with no blood supply to deliver antioxidants directly. Both tissues express OCTN1 (SLC22A4), a dedicated ergothioneine transporter that actively imports ergothioneine from the aqueous humor. The accumulation is targeted because ergothioneine is specifically effective at quenching singlet oxygen, the primary reactive species UV generates in the lens, and because activating the Nrf2 antioxidant pathway provides broader cellular defense.

What antioxidants are naturally found in the human lens?

The lens naturally concentrates several antioxidants, including glutathione (its primary antioxidant defense), ascorbic acid (vitamin C), alpha-tocopherol (vitamin E), and ergothioneine. Ergothioneine's presence is notable because its accumulation is mediated by a dedicated transporter (OCTN1) expressed specifically in lens epithelial cells, rather than by passive diffusion. Glutathione is synthesized within the lens; ergothioneine must be imported from external sources via the aqueous humor.

How does OCTN1 work in the eye?

OCTN1 (SLC22A4) is a membrane transporter protein expressed in lens epithelial cells and retinal pigment epithelium. It uses the sodium gradient across the cell membrane to actively pump ergothioneine from extracellular fluid (aqueous humor or interstitial fluid) into the cell interior. The transporter is highly selective for ergothioneine, carrying it with far greater efficiency than any other substrate tested. This active mechanism concentrates ergothioneine well above levels that passive diffusion would achieve.

Why is the lens vulnerable to oxidative stress?

Three factors combine to make the lens unusually vulnerable. First, lens proteins are never replaced — every oxidative injury to a crystallin protein is permanent. Second, the lens has no blood supply and relies on the aqueous humor for antioxidant delivery, limiting what it can access. Third, the lens directly absorbs UV radiation entering the eye, generating singlet oxygen and hydrogen peroxide in the tissue continuously. The lens compensates through active import of specific antioxidants including ergothioneine, but the structural vulnerability remains.

What causes oxidative damage to the eye lens?

UV radiation is the primary driver, generating singlet oxygen and hydrogen peroxide directly in lens tissue. Metal ions (iron, copper) that accumulate in the aging lens amplify the damage through Fenton chemistry, converting hydrogen peroxide into the highly reactive hydroxyl radical. Both singlet oxygen and hydroxyl radicals oxidize crystallin proteins, causing them to aggregate and scatter light. Because lens proteins are never replaced, this oxidative damage is cumulative and permanent over a lifetime.

Sources & References

1. 1RTHM-00154·Gründemann, Dirk et al. (2005). “Discovery of the ergothioneine transporter..” Proceedings of the National Academy of Sciences of the United States of America.Study breakdown →PubMed →↩
2. 2RTHM-01129·Tucker, Robert A J et al. (2019). “Specificity of the ergothioneine transporter natively expressed in HeLa cells..” Biochemical and biophysical research communications.Study breakdown →PubMed →↩
3. 3RTHM-01527·Gründemann, Dirk et al. (2022). “The ergothioneine transporter (ETT): substrates and locations, an inventory..” FEBS letters.Study breakdown →PubMed →↩
4. 4RTHM-00678·Cheah, Irwin K et al. (2021). “Ergothioneine, recent developments..” Redox biology.Study breakdown →PubMed →↩
5. 5RTHM-01933·Li, Yongchao et al. (2024). “Ergothioneine Protects Against UV-Induced Oxidative Stress Through the PI3K/AKT/Nrf2 Signaling Pathway..” Clinical.Study breakdown →PubMed →↩
6. 6RTHM-00936·Ames, Bruce N (2018). “Prolonging healthy aging: Longevity vitamins and proteins..” Proceedings of the National Academy of Sciences of the United States of America.Study breakdown →PubMed →↩
7. 7RTHM-00004·Shukla, Y et al. (1981). “Ergothioneine content in normal and senile human cataractous lenses..” The Indian journal of medical research.Study breakdown →PubMed →↩